“If partnership with large upfront cash then can get up to $2-3”
— not happening. The $50M financing/dilution news makes it clear. You will rather see a death spiral when LP pumps a combo trial without any cash commitment from big pharma. This will confirm 2 things:
1) Endless dilution for the foreseeable future.
2) None of the big pharma sees monetization potential in NWBO platform.
The way this inept mute nonmanagement has not performed, expect the single approval pr with zero follow up. So many here are so frustrated that we will pull the trigger on that blurb and never look back, except in disgust.